HeRO Graft

Joy Garg, MD

CryoLife — Tue, 21 May 2013 14:54:11 +0000

Joy Garg, MD

CryoLife — Tue, 21 May 2013 14:51:31 +0000

Charles M. Eichler

CryoLife — Tue, 26 Mar 2013 21:01:55 +0000

Gary Tannenbaum, MD

CryoLife — Tue, 26 Mar 2013 20:57:13 +0000

Angelo Santos, MD

CryoLife — Tue, 16 Oct 2012 17:04:56 +0000

Irene Goldstein, MD

CryoLife — Tue, 19 Jun 2012 19:13:13 +0000

Hemosphere is Now a CryoLife® Company!

CryoLife — Thu, 17 May 2012 14:45:26 +0000

May 2012 – Steven G. Anderson, president and chief executive officer of CryoLife, said, “The acquisition of Hemosphere significantly advances our strategic initiative to reposition CryoLife’s product portfolio with higher growth, higher margin medical devices for cardiac and vascular surgery. We believe there is a significant opportunity for our sales team to leverage their strong relationships with vascular surgeons, many of whom already use our preserved human veins and arteries to provide arteriovenous (AV) access for ESRD patients, to introduce and to expand utilization of the HeRO Graft in the U.S. In addition, we believe that potential product enhancements and international sales represent incremental HeRO Graft growth opportunities.”

Read the full press release. To learn more about CryoLife visit CryoLife.com.

Fernando Kafie, MD, FACS

CryoLife — Wed, 09 May 2012 15:47:49 +0000

HeRO News Bulletin

CryoLife — Thu, 29 Mar 2012 16:10:53 +0000

HeRO News Bulletin Eleven

Robert C. Davies, MD

CryoLife — Wed, 28 Mar 2012 15:26:09 +0000